Johnson & Johnson (JNJ) is a publicly traded Healthcare sector company. As of May 20, 2026, JNJ trades at $230.00 with a market cap of $551.06B and a P/E ratio of 26.42. JNJ moved -0.35% today. Year to date, JNJ is +10.92%; over the trailing twelve months it is +50.83%. Its 52-week range spans $140.68 to $251.71. Analyst consensus is buy with an average price target of $264.75. Rallies surfaces JNJ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
JNJ financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. JNJ recently traded at $230.00. Market cap is $551.06B. P/E ratio is 26.42. Revenue is $96.36B.
| Metric | Value |
|---|---|
| Price | $230.00 |
| Market Cap | $551.06B |
| P/E Ratio | 26.42 |
| EPS | $8.73 |
| Dividend Yield | 1.34% |
| 52-Week High | $251.71 |
| 52-Week Low | $140.68 |
| Volume | 3.37M |
| Avg Volume | 0 |
| Revenue (TTM) | $96.36B |
| Net Income | $21.04B |
| Gross Margin | 67.82% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $94.19B | $26.80B | $11.13 |
| 2024 | $88.82B | $14.07B | $5.84 |
| 2023 | $85.16B | $35.15B | $13.88 |
| 2022 | $93.78B | $20.88B | $7.93 |
18 analysts cover JNJ: 0 strong buy, 12 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $264.75.